IN2014DN06617A - - Google Patents

Info

Publication number
IN2014DN06617A
IN2014DN06617A IN6617DEN2014A IN2014DN06617A IN 2014DN06617 A IN2014DN06617 A IN 2014DN06617A IN 6617DEN2014 A IN6617DEN2014 A IN 6617DEN2014A IN 2014DN06617 A IN2014DN06617 A IN 2014DN06617A
Authority
IN
India
Prior art keywords
methods
administration
making
same
calcium
Prior art date
Application number
Other languages
English (en)
Inventor
Manish S Shah
Ray J Difalco
Original Assignee
Cerolife Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerolife Llc filed Critical Cerolife Llc
Publication of IN2014DN06617A publication Critical patent/IN2014DN06617A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN6617DEN2014 2013-03-15 2014-03-15 IN2014DN06617A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361798689P 2013-03-15 2013-03-15
PCT/US2014/029941 WO2014145219A1 (en) 2013-03-15 2014-03-15 Orally administrable compositions comprising calcium

Publications (1)

Publication Number Publication Date
IN2014DN06617A true IN2014DN06617A (pt) 2015-05-22

Family

ID=51537910

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6617DEN2014 IN2014DN06617A (pt) 2013-03-15 2014-03-15

Country Status (5)

Country Link
US (2) US10675246B2 (pt)
EP (1) EP2968176B1 (pt)
ES (1) ES2749752T3 (pt)
IN (1) IN2014DN06617A (pt)
WO (1) WO2014145219A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014145219A1 (en) * 2013-03-15 2014-09-18 Cerolife Llc Orally administrable compositions comprising calcium
KR101683635B1 (ko) * 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
KR20180062063A (ko) * 2016-11-30 2018-06-08 (주) 메티메디제약 서방형 항암용 약학 조성물
CN110368369B (zh) * 2019-08-30 2021-11-05 广州新济药业科技有限公司 钙补充剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
EP1591143A1 (en) 2004-04-26 2005-11-02 Schaper & Brümmer Gmbh & Co. Kg Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
US20070128272A1 (en) * 2005-12-07 2007-06-07 Zerbe Horst G Multi-vitamin and mineral supplement
US20080166423A1 (en) * 2007-01-06 2008-07-10 Renjit Sundharadas Combination Medication for Treating the Effects of Stomach Acid Reduction Medication on Bone Integrity
WO2009140341A2 (en) 2008-05-13 2009-11-19 Dr. Reddy's Laboratories Ltd. Atorvastatin compositions
US8865213B2 (en) 2009-12-30 2014-10-21 Usv Limited Modified release pharmaceutical compositions
US20120244218A1 (en) 2011-03-25 2012-09-27 Durkee Shane E Calcium supplement
WO2014145219A1 (en) * 2013-03-15 2014-09-18 Cerolife Llc Orally administrable compositions comprising calcium

Also Published As

Publication number Publication date
US20160022586A1 (en) 2016-01-28
EP2968176B1 (en) 2019-08-21
EP2968176A1 (en) 2016-01-20
WO2014145219A1 (en) 2014-09-18
EP2968176A4 (en) 2016-11-23
US10675246B2 (en) 2020-06-09
US20200297640A1 (en) 2020-09-24
ES2749752T3 (es) 2020-03-23

Similar Documents

Publication Publication Date Title
GEP20217239B (en) Pharmaceutical composition
HK1214171A1 (zh) 賽尼克韋羅組合物及其製備和使用方法
MX2015010921A (es) Compuestos de carbazol utiles como inhibidores de bromodominio.
MX2020005181A (es) Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam).
MX2016004927A (es) Composiciones utiles para tratar trastornos relacionados con kit.
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
TN2015000411A1 (en) Ceftolozane antibiotic compositions
HK1217896A1 (zh) 用於治療廣泛性發展障礙的複合物及方法
MX2015011837A (es) Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada.
PL3560558T3 (pl) Kompozycje nawozów oraz sposoby ich wytwarzania i stosowania
GEP20217240B (en) Pharmaceutical composition
IN2013MU03641A (pt)
PH12016500495A1 (en) Compositions for the treatment of hypertension and/or fibrosis
PH12016500497A1 (en) Compositions for the treatment of hypertension and/or fibrosis
IN2014DN06617A (pt)
GEP20217236B (en) Composition comprising pentose and polyphenolic compound
MX2015016603A (es) Composiciones de corticosteroides.
EP2994147A4 (en) Compositions and methods for the treatment of tinnitus
MY167350A (en) Fat-and-oil composition and chocolate
IN2013CH02437A (pt)
AU363054S (en) Spigot
IN2014CH00686A (pt)
AU363941S (en) Spider fitting